GlassScriptPhysician profile
Diane H Eden
NPI 1720052772
$1,831.88
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,439 · 2020: $323 · 2021: $20.47 · 2022: $49.02.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $396.27 | 2019-2020 | |
| Lundbeck LLC | $271.47 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $225.51 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $200.85 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.27 | 2019-2020 | |
| Allergan, INC. | $117.85 | 2019-2020 | |
| Shire North American Group INC | $111.95 | 2019 | |
| Sunovion Pharmaceuticals INC. | $76.06 | 2019-2020 | |
| Abbvie INC. | $69.49 | 2021-2022 | |
| Bausch Health US, LLC | $63.76 | 2019-2020 | |
| Brainsway USA INC | $47.29 | 2019 | |
| Neurocrine Biosciences, INC. | $35.55 | 2019 | |
| Neos Therapeutics, LP | $23.00 | 2019 | |
| Jazz Pharmaceuticals INC. | $21.64 | 2019 | |
| Neuronetics, INC. | $13.74 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Validus Pharmaceuticals LLC | $12.79 | 2019 | |
| Adlon Therapeutics L.P. | $12.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Eden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.